# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-25-058852
Filing Date
2025-04-25
Accepted
2025-04-25 17:05:02
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | fgen-defa14a-2025_na.htm | DEFA14A | 15737
2 | GRAPHIC | img148970595_0.jpg | GRAPHIC | 491159
3 | GRAPHIC | img148970595_1.jpg | GRAPHIC | 664295
| Complete submission text file | 0000950170-25-058852.txt |  | 1607723

Mailing Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36740 | Film No.: 25875108
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)